Circulatory support in infants with post-cardiopulmonary bypass left ventricular dysfunction using a left ventricular

N E Moat1, A Pawade, B C Lewis

  • 1Wessex Cardiothoracic Centre, Southampton General Hospital, UK.

Insights

Left ventricular assist devices offer a promising alternative to extracorporeal membrane oxygenation for infants with post-cardiac surgery ventricular dysfunction. This study shows feasibility and potential benefits in small pediatric patients.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Surgery
  • Biomedical Engineering

Background:

  • Extracorporeal membrane oxygenation (ECMO) is commonly used for pediatric circulatory support after cardiopulmonary bypass.
  • However, ECMO results are disappointing in infants with predominant left ventricular failure.

Observation:

  • Three infants (<10 kg) with severe left ventricular dysfunction post-cardiac surgery were managed with a left ventricular assist device (LVAD).
  • The LVAD provided circulatory support for weaning from bypass or managing postoperative dysfunction.
  • Support duration ranged from 40 to 146 hours using a closed-loop system with a constrained vortex pump.

Findings:

  • One infant recovered fully and was discharged.
  • Another achieved circulatory recovery but sustained neurological damage.
  • The third infant died from progressive left ventricular dysfunction.

Implications:

  • LVADs are technically feasible and effective in small infants with left ventricular dysfunction after cardiac surgery.
  • LVADs may be a more appropriate circulatory support option than ECMO for this specific patient group.
  • Further research is warranted to optimize LVAD use in pediatric cardiac surgery.

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...